Brady Martz Wealth Solutions LLC Takes $554,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Brady Martz Wealth Solutions LLC acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 1,028 shares of the medical equipment provider's stock, valued at approximately $554,000.

Other large investors also recently added to or reduced their stakes in the company. Intech Investment Management LLC grew its holdings in Intuitive Surgical by 6.2% during the 2nd quarter. Intech Investment Management LLC now owns 21,279 shares of the medical equipment provider's stock worth $9,466,000 after acquiring an additional 1,244 shares during the period. Benjamin F. Edwards & Company Inc. grew its stake in shares of Intuitive Surgical by 5.5% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 6,450 shares of the medical equipment provider's stock worth $2,870,000 after purchasing an additional 338 shares during the period. King Luther Capital Management Corp increased its holdings in Intuitive Surgical by 2.1% in the second quarter. King Luther Capital Management Corp now owns 5,670 shares of the medical equipment provider's stock valued at $2,522,000 after purchasing an additional 114 shares during the last quarter. AE Wealth Management LLC lifted its stake in Intuitive Surgical by 24.5% in the second quarter. AE Wealth Management LLC now owns 3,822 shares of the medical equipment provider's stock valued at $1,700,000 after buying an additional 752 shares during the period. Finally, Sei Investments Co. boosted its holdings in Intuitive Surgical by 1.4% during the second quarter. Sei Investments Co. now owns 527,686 shares of the medical equipment provider's stock worth $234,734,000 after buying an additional 7,080 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In other news, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the transaction, the executive vice president now directly owns 7,066 shares of the company's stock, valued at $3,638,990. This represents a 26.54 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jamie Samath sold 270 shares of the stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the transaction, the chief financial officer now owns 8,757 shares of the company's stock, valued at $4,730,093.55. The trade was a 2.99 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 48,190 shares of company stock valued at $25,012,927. 0.80% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Citigroup increased their price target on shares of Intuitive Surgical from $567.00 to $640.00 and gave the company a "buy" rating in a research report on Wednesday, December 11th. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Tuesday, November 19th. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a report on Friday, October 18th. Raymond James boosted their target price on Intuitive Surgical from $500.00 to $540.00 and gave the company an "outperform" rating in a research note on Monday, October 14th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and boosted their price target for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $554.17.

Intuitive Surgical Trading Up 1.5 %

ISRG stock traded up $8.56 during trading on Monday, reaching $592.64. 2,630,118 shares of the stock were exchanged, compared to its average volume of 1,158,623. The firm has a market cap of $211.09 billion, a P/E ratio of 95.28, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. The firm's 50 day moving average is $540.66 and its 200 day moving average is $499.64. Intuitive Surgical, Inc. has a twelve month low of $362.14 and a twelve month high of $597.68.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to analysts' expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.